• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激诱导的 1,N6- 烯脱氧腺苷加合物形成促进肝癌发生。

Oxidative stress-induced 1, N6-ethenodeoxyadenosine adduct formation contributes to hepatocarcinogenesis.

机构信息

Department of Gastroenterology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, PR China.

出版信息

Oncol Rep. 2013 Mar;29(3):875-84. doi: 10.3892/or.2013.2227. Epub 2013 Jan 4.

DOI:10.3892/or.2013.2227
PMID:23292006
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3597589/
Abstract

Numerous studies have found that oxidative stress-derived 1, N6-ethenodeoxyadenosine (ε-dA) can act as a driving force towards hepatocellular carcinoma (HCC) in cancer-prone liver diseases. The aim of the present study was to determine the oxidative stress status and the occurrence of ε-dA in HCC and adjacent non-tumor liver tissue, and to clarify whether the occurrence of ε-dA is related to liver inflammatory activity, fibrosis and mutant p53 expression. Oxidative stress-related parameters were examined in tumor and (or) non-tumor liver tissues of 32 patients with HCC. ε-dA, mutant p53 and proliferating cell nuclear antigen (PCNA) were immunohistochemically investigated in control, HCC and non-tumor liver tissues. The total antioxidant capacity and total superoxide dismutase activity of HCC tissues were lower compared to those of non-tumor tissues (P<0.05 vs. P<0.001). The prevalence of ε-dA in HCC was significantly higher compared to control (P<0.0001) and non-tumor liver tissues (P<0.001). A significant correlation between the positive rate of ε-dA and mutant p53 was observed (r=0.5162, P<0.01). The positive rate of PCNA in HCC was significantly higher compared to control (P<0.0001) and non-tumor liver tissues (P<0.0001). There was a possible link between the formation of ε-dA and chronic inflammation and fibrosis. Therefore, ε-dA lesions may gradually accumulate in chronic liver diseases, and partially contribute to mutant p53 overexpression and excessive cell proliferation, making it a potential mechanism in oxidative stress-mediated hepatocarcinogenesis.

摘要

大量研究发现,氧化应激衍生的 1,N6-烯丙基脱氧腺苷(ε-dA)可作为癌症易患肝脏疾病中肝细胞癌(HCC)的驱动力。本研究旨在确定 HCC 及相邻非肿瘤肝组织中的氧化应激状态和 ε-dA 的发生情况,并阐明 ε-dA 的发生是否与肝炎症活动、纤维化和突变型 p53 表达有关。检查了 32 例 HCC 患者肿瘤和(或)非肿瘤肝组织中的氧化应激相关参数。在对照、HCC 和非肿瘤肝组织中进行了 ε-dA、突变型 p53 和增殖细胞核抗原(PCNA)的免疫组织化学研究。与非肿瘤组织相比,HCC 组织的总抗氧化能力和总超氧化物歧化酶活性均较低(P<0.05 比 P<0.001)。与对照(P<0.0001)和非肿瘤肝组织(P<0.001)相比,HCC 中 ε-dA 的发生率显著更高。观察到 ε-dA 阳性率与突变型 p53 之间存在显著相关性(r=0.5162,P<0.01)。HCC 中 PCNA 的阳性率明显高于对照(P<0.0001)和非肿瘤肝组织(P<0.0001)。ε-dA 损伤的形成与慢性炎症和纤维化之间可能存在联系。因此,ε-dA 损伤可能在慢性肝病中逐渐积累,并部分导致突变型 p53 过表达和过度细胞增殖,成为氧化应激介导的肝癌发生的潜在机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/085161202b0f/OR-29-03-0875-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/d91313e13fb7/OR-29-03-0875-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/49b343382483/OR-29-03-0875-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/e128016258ab/OR-29-03-0875-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/8e2a275642c8/OR-29-03-0875-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/0e52b43e5f2b/OR-29-03-0875-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/d6dca227f767/OR-29-03-0875-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/085161202b0f/OR-29-03-0875-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/d91313e13fb7/OR-29-03-0875-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/49b343382483/OR-29-03-0875-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/e128016258ab/OR-29-03-0875-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/8e2a275642c8/OR-29-03-0875-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/0e52b43e5f2b/OR-29-03-0875-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/d6dca227f767/OR-29-03-0875-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/286c/3597589/085161202b0f/OR-29-03-0875-g06.jpg

相似文献

1
Oxidative stress-induced 1, N6-ethenodeoxyadenosine adduct formation contributes to hepatocarcinogenesis.氧化应激诱导的 1,N6- 烯脱氧腺苷加合物形成促进肝癌发生。
Oncol Rep. 2013 Mar;29(3):875-84. doi: 10.3892/or.2013.2227. Epub 2013 Jan 4.
2
Decreased levels of nitric oxide production and nitric oxide synthase-2 expression are associated with the development and metastasis of hepatocellular carcinoma.一氧化氮生成和一氧化氮合酶-2 表达水平降低与肝癌的发生和转移有关。
Mol Med Rep. 2012 Dec;6(6):1261-6. doi: 10.3892/mmr.2012.1096. Epub 2012 Sep 24.
3
Liver-specific expressions of HBx and src in the p53 mutant trigger hepatocarcinogenesis in zebrafish.在斑马鱼中,p53突变体中HBx和src的肝脏特异性表达引发肝癌发生。
PLoS One. 2013 Oct 9;8(10):e76951. doi: 10.1371/journal.pone.0076951. eCollection 2013.
4
Immunohistochemical detection of 1,N6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepato-carcinogenesis.在易患肝癌的疾病所影响的人肝脏细胞核中对1,N6-乙烯基脱氧腺苷进行免疫组织化学检测。
Carcinogenesis. 2004 Jun;25(6):1027-31. doi: 10.1093/carcin/bgh089. Epub 2004 Jan 23.
5
[Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].[肝硬化和肝细胞癌中p53和bcl-2蛋白对细胞凋亡和细胞增殖的调控]
Hunan Yi Ke Da Xue Xue Bao. 1999;24(4):325-8.
6
TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.TREM-2 通过多种保护机制保护肝脏免受肝细胞癌的侵害。
Gut. 2021 Jul;70(7):1345-1361. doi: 10.1136/gutjnl-2019-319227. Epub 2020 Sep 9.
7
Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.TAp73α、p53、增殖细胞核抗原(PCNA)在肝癌中的表达及临床意义与细胞凋亡
World J Gastroenterol. 2005 May 14;11(18):2709-13. doi: 10.3748/wjg.v11.i18.2709.
8
The chemokine receptor CCR10 promotes inflammation-driven hepatocarcinogenesis via PI3K/Akt pathway activation.趋化因子受体 CCR10 通过激活 PI3K/Akt 通路促进炎症驱动的肝癌发生。
Cell Death Dis. 2018 Feb 14;9(2):232. doi: 10.1038/s41419-018-0267-9.
9
Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.增殖标志物Ki-67和p53蛋白在HBV或HCV肝硬化中的肝脏表达与发育异常肝细胞变化及肝细胞癌的关系。
J Viral Hepat. 2005 Nov;12(6):635-41. doi: 10.1111/j.1365-2893.2005.00635.x.
10
Down-regulation of tumor suppressor gene PTEN, overexpression of p53, plus high proliferating cell nuclear antigen index predict poor patient outcome of hepatocellular carcinoma after resection.肿瘤抑制基因PTEN的下调、p53的过表达以及高增殖细胞核抗原指数预示着肝细胞癌患者切除术后预后不良。
Oncol Rep. 2007 Dec;18(6):1417-26.

引用本文的文献

1
The load of hepatitis B virus reduces the immune checkpoint inhibitors efficiency in hepatocellular carcinoma patients.乙肝病毒载量会降低免疫检查点抑制剂对肝细胞癌患者的疗效。
Front Immunol. 2024 Nov 27;15:1480520. doi: 10.3389/fimmu.2024.1480520. eCollection 2024.
2
Advances on molecular mechanism of hepatitis B virus-induced hepatocellular carcinoma.乙型肝炎病毒诱导肝细胞癌的分子机制研究进展。
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Feb 25;50(1):113-122. doi: 10.3724/zdxbyxb-2021-0032.
3
Roles of Reactive Oxygen Species in Biological Behaviors of Prostate Cancer.

本文引用的文献

1
Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.非酒精性脂肪性肝病与肝细胞癌:沉甸甸的关联。
Hepatology. 2010 May;51(5):1820-32. doi: 10.1002/hep.23594.
2
Immunity, inflammation, and cancer.免疫、炎症与癌症。
Cell. 2010 Mar 19;140(6):883-99. doi: 10.1016/j.cell.2010.01.025.
3
High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases.癌症易患肝脏疾病患者尿液中脂质过氧化衍生 DNA 损伤的排泄量较高。
活性氧在前列腺癌生物学行为中的作用。
Biomed Res Int. 2020 Sep 29;2020:1269624. doi: 10.1155/2020/1269624. eCollection 2020.
4
Molecular Mechanisms Underlying Hepatocellular Carcinoma Induction by Aberrant NRF2 Activation-Mediated Transcription Networks: Interaction of NRF2-KEAP1 Controls the Fate of Hepatocarcinogenesis.异常 NRF2 激活介导的转录网络导致肝细胞癌发生的分子机制:NRF2-KEAP1 相互作用控制肝癌发生的命运。
Int J Mol Sci. 2020 Jul 29;21(15):5378. doi: 10.3390/ijms21155378.
5
Dual effects of the Nrf2 inhibitor for inhibition of hepatitis C virus and hepatic cancer cells.Nrf2 抑制剂抑制丙型肝炎病毒和肝癌细胞的双重作用。
BMC Cancer. 2018 Jun 25;18(1):680. doi: 10.1186/s12885-018-4588-y.
6
Diagnostic and Prognostic Value of Talin-1 and Midkine as Tumor Markers in Hepatocellular Carcinoma in Egyptian Patients.塔林-1和中期因子作为埃及患者肝细胞癌肿瘤标志物的诊断和预后价值
Asian Pac J Cancer Prev. 2018 Jun 25;19(6):1503-1508. doi: 10.22034/APJCP.2018.19.6.1503.
7
Detection of a lipid peroxidation-induced DNA adduct across liver disease stages.跨肝病各阶段检测脂质过氧化诱导的DNA加合物。
Hepatobiliary Surg Nutr. 2018 Apr;7(2):85-97. doi: 10.21037/hbsn.2017.06.01.
8
Natural Dietary Pigments: Potential Mediators against Hepatic Damage Induced by Over-The-Counter Non-Steroidal Anti-Inflammatory and Analgesic Drugs.天然膳食色素:对抗非处方非甾体抗炎和镇痛药引起的肝损伤的潜在调节剂。
Nutrients. 2018 Jan 24;10(2):117. doi: 10.3390/nu10020117.
9
Clinical implication of Keap1 and phosphorylated Nrf2 expression in hepatocellular carcinoma.Keap1和磷酸化Nrf2表达在肝细胞癌中的临床意义
Cancer Med. 2016 Oct;5(10):2678-2687. doi: 10.1002/cam4.788. Epub 2016 Sep 20.
10
Slow repair of lipid peroxidation-induced DNA damage at p53 mutation hotspots in human cells caused by low turnover of a DNA glycosylase.由于一种DNA糖基化酶的低周转率,人类细胞中p53突变热点处脂质过氧化诱导的DNA损伤修复缓慢。
Nucleic Acids Res. 2014 Aug;42(14):9033-46. doi: 10.1093/nar/gku520. Epub 2014 Jul 31.
Mutat Res. 2010 Jan 5;683(1-2):23-8. doi: 10.1016/j.mrfmmm.2009.10.002.
4
Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease.乙醇诱导的细胞色素P4502E1在酒精性肝病中导致致癌性乙烯基-DNA损伤。
Hepatology. 2009 Aug;50(2):453-61. doi: 10.1002/hep.22978.
5
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?通过活性氧介导的机制靶向癌细胞:一种激进的治疗方法?
Nat Rev Drug Discov. 2009 Jul;8(7):579-91. doi: 10.1038/nrd2803. Epub 2009 May 29.
6
Redox mechanisms in hepatic chronic wound healing and fibrogenesis.肝脏慢性伤口愈合与纤维化形成中的氧化还原机制
Fibrogenesis Tissue Repair. 2008 Oct 13;1(1):5. doi: 10.1186/1755-1536-1-5.
7
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis.肝细胞癌:流行病学与分子致癌机制
Gastroenterology. 2007 Jun;132(7):2557-76. doi: 10.1053/j.gastro.2007.04.061.
8
Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan.台湾地区尿8-氧代脱氧鸟苷、黄曲霉毒素B1暴露、乙型肝炎病毒感染与肝细胞癌
Carcinogenesis. 2007 May;28(5):995-9. doi: 10.1093/carcin/bgl234. Epub 2006 Nov 24.
9
Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells.乙肝病毒复制会在HepAD38肝细胞中引发氧化应激。
Mol Cell Biochem. 2006 Oct;290(1-2):79-85. doi: 10.1007/s11010-006-9167-x. Epub 2006 Sep 8.
10
Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair.慢性炎症和氧化应激在癌症发生与持续发展中的作用:脂质过氧化、DNA损伤及修复的作用
Langenbecks Arch Surg. 2006 Sep;391(5):499-510. doi: 10.1007/s00423-006-0073-1. Epub 2006 Aug 15.